about
Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigraNeurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preferenceExpression of neurotensin receptors in human corneal keratocytesTwo populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distributionIncreased plasma neurotensin concentrations in patients with Parkinson's diseaseRole of dopamine D3 receptors in thermoregulation: a reappraisalChromosomal localization of mouse and human neurotensin receptor genesStromal-cell-derived factor 1alpha /CXCL12 modulates high-threshold calcium currents in rat substantia nigraConstitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neuronsSpinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated ratsHyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitroAutomated keratoconus detection using the EyeSys videokeratoscope.Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro.Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.Neurotensin: an endogenous psychostimulant?Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.Bilateral neuroinflammatory processes in visual pathways induced by unilateral ocular hypertension in the ratDevelopmental pattern of neurotensin content in rat hypothalamic neurons cultured in serum-free medium: comparison with in vivo data.The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692Feeding mice with diets containing mercury-contaminated fish flesh from French Guiana: a model for the mercurial intoxication of the Wayana Amerindians.Chemokines and chemokine receptors: new actors in neuroendocrine regulations.Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system.Current status of chemokines in the adult CNS.Opioid and chemokine receptor crosstalk: a promising target for pain therapy?Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: a combined in situ hybridization and receptor light-microscopic radioautographic study.Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms.Combined 3DISCO clearing method, retrograde tracer and ultramicroscopy to map corneal neurons in a whole adult mouse trigeminal ganglion.CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation.Adaptive responsiveness of some central receptors to the denervation of heterologous afferent fibers: functional significance and possible behavioral consequences.Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP).Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.NT agonist regulates expression of nuclear high-affinity neurotensin receptors.Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells.Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor.[Chemokines: new insights in the treatment of glaucoma and inflammatory diseases of the ocular surface].Pharmacological and molecular characterization of the neurotensin receptor expressed in Sf9 cells.Neurotensin and neuroendocrine regulation.Effect of an inhibitor of aromatization, 1,4,6 androstatriene-3,17-dione (ATD) on LH release and steroid binding in hypothalamus of adult female rats.
P50
Q22003900-D1DB261F-24EA-4D61-8985-AE6F005B3534Q24634249-FDA29407-C970-4B2B-9B96-7FD80B0430A9Q28201549-96FCA5C3-29D2-43E1-A33A-296D87C6091FQ28283120-C19ED8AC-3D8F-4456-958A-F1D7BFEE596AQ28366091-EF14962D-1641-4136-A0AA-67350901B426Q28370816-241CEC39-3B53-4756-A26C-F7BA9E9D9C68Q28507408-8C55F921-0BF4-4F2F-B67E-4FCDA47D0486Q28569795-29F2AFE0-75AB-4EF7-9381-1C75C878873FQ28574923-EE566664-1680-46C5-A6C1-A766BDBEFE99Q28577588-BE8F77ED-D741-4A5C-8BAE-8C8B6DDBBAE8Q30513663-CEAAA654-0715-47CC-B3D3-9D5470F9B911Q30874005-9384AD51-C231-4ED5-A73F-F4C165951EC0Q31132977-514C2EA2-9332-4BBA-9E71-AE7B72148F71Q34426946-87E67F06-35D2-485F-96E6-56EA131DD714Q34489928-9D3BE9B3-B178-4917-89A7-6D1D80B25AE1Q36071006-D5B3C833-7791-4B1E-8F7D-EB565E0CCEEBQ36372561-C5F4DEF6-1646-45FC-897F-32E601DA9BD5Q36599983-1697B7C9-88FA-4C12-AE1A-F327EC52C89EQ36710472-2A8F7CEC-786D-41C7-9722-8BC4D1013047Q36787413-4C32B6D6-F66E-4CD9-8B99-71FFB28FA839Q36915456-9F9A508C-A41B-490F-AF92-BC84442978BAQ36975183-AAF33F98-3F97-49E8-9EDC-DAE0F1F2CDBCQ37771976-F39D324B-4838-458E-8B1D-176661781C4AQ37896669-E573FEA0-7F21-494B-AC5B-2974DB55A970Q38085956-3A5632B2-BD10-409E-B064-49A71674B482Q38318330-7747F875-9A8C-4246-B605-F4711276E93CQ38327934-4682590A-1D82-419B-A235-1BDFDD645FBBQ39162284-1E82804E-948A-4764-A77D-39FE015E9359Q39162293-E0C42400-2FBE-4D04-A0FF-8680D32667A1Q39332349-71D88626-A1D8-46FF-9E1A-5660CA1AC4CFQ39511411-CC50B628-CFF4-4481-938F-5D90A7E49428Q40185676-66AB768F-5047-4211-A944-3AB877787DFDQ40509061-A0D7F1C4-2F69-4B65-B045-F062695F0A7CQ40589593-41B2A26F-B2BC-4630-AF9A-4244ED5746CBQ40850285-A98078F9-D529-4F05-B329-A02380AA3358Q41016202-34E84F04-5258-43AE-8466-185742F332A7Q41183146-A0464AE3-C4DF-4C84-A0B3-B967C5B2505EQ41199455-E43F46EC-4116-4DEF-A2D8-FC06B3E181DBQ41430803-127275F2-5AF7-49D7-8CFA-A0F2B106A0F0Q41478834-5B503311-2253-4FD4-8DDF-51206B8A0F8D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0409-5361
@en
name
William Rostene
@ast
William Rostene
@en
William Rostene
@es
William Rostene
@nl
type
label
William Rostene
@ast
William Rostene
@en
William Rostene
@es
William Rostene
@nl
prefLabel
William Rostene
@ast
William Rostene
@en
William Rostene
@es
William Rostene
@nl
P106
P31
P496
0000-0003-0409-5361